Non-clinical development of CER-001

Frontiers in Pharmacology

Volumn 6, Issue OCT, 2015, Pages

  Barbaras, Ronald ^a  

^a Cerenis Therapeutics SA   (France)

Author keywords

Apolipoprotein A I; Atherosclerosis; Cardiovascular diseases; Cholesterol; HDL

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN A1; CER 001; CYCLIC AMP; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HIGH DENSITY LIPOPROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VASOACTIVE AGENT;

ARTERIAL WALL THICKNESS; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CHRONIC INFLAMMATION; COLUMN CHROMATOGRAPHY; COMPLEX FORMATION; CONTROLLED STUDY; CORONARY BLOOD VESSEL; DEVELOPING COUNTRY; DISEASE COURSE; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME ACTIVITY; FAMILIAL HYPERCHOLESTEROLEMIA; HUMAN; HUMAN CELL; HYPERCHOLESTEROLEMIA; HYPOALPHALIPOPROTEINEMIA; IN VITRO STUDY; INTRAVASCULAR ULTRASOUND; LIPID DIET; LIPID TRANSPORT; NONHUMAN; OXIDATIVE STRESS; REVIEW; UPREGULATION;

EID: 84947275453     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2015.00220     Document Type: Review

References (35)

1. Ameli, S., Hultgardh-Nilsson, A., Cercek, B., Shah, P. K., Forrester, J. S., Ageland, H., et al. (1994). Recombinant apolipoprotein A-I Milano reduces intimal thickening after balloon injury in hypercholesterolemic rabbits. Circulation 90, 1935-1941. doi: 10.1161/01.CIR.90.4.1935
2. Andrews, J., Kataoka, Y., Duong, M., Fendler, J., Nguyen, T., Puri, R., et al. (2014). "Regression of coronary atherosclerosis in response to infusion of High-Density lipoprotein-mimetic agent CER-001 in patients with acute coronary syndrome". in Proceedings of the 19th Annual Scientific Meeting of the International Society of Cardiovascular Pharmacotherapy, Adelaide, SA.
3. Attie, A. D., Kastelein, J. P., and Hayden, M. R. (2001). Pivotal role of ABCA1 in reverse cholesterol transport influencing HDL levels and susceptibility to atherosclerosis. J. Lipid Res. 42, 1717-1726.
4. Badimon, J. J., Badimon, L., and Fuster, V. (1990). Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit. J. Clin. Invest. 85, 1234-1241. doi: 10.1172/JCI114558
5. Badimon, J. J., Badimon, L., Galvez, A., Dische, R., and Fuster, V. (1989). High density lipoprotein plasma fractions inhibit aortic fatty streaks in cholesterol-fed rabbits. Lab. Invest. 60, 455-461.
6. Baron, R., Goffinet, M., Sy, G., Schwendeman, A., Keyserling, C., Barbaras, R., et al. (2010). CER-001 a Novel HDL Mimetic: Characterization of In Vitro and In Vivo Biological Activities. Chicago: American Heart Association. A. (Circulation).
7. Bortnick, A. E. A., Rothblat, G. H. G. H., Stoudt, G., Hoppe, K. L., Royer, L. J., Mcneish, J., et al. (2000). The correlation of ATP-binding cassette 1 mRNA levels with cholesterol efflux from various cell lines. J. Biol. Chem. 275, 28634-28640. doi: 10.1074/jbc.M003407200
8. Cogny, A., Atger, V., Paul, J. L., Soni, T., and Moatti, N. (1996). High-density lipoprotein 3 physicochemical modifications induced by interaction with human polymorphonuclear leucocytes affect their ability to remove cholesterol from cells. Biochem. J. 314(Pt 1), 285-292. doi: 10.1042/bj3140285
9. Feng, Y., Van Craeyveld, E., Jacobs, F., Lievens, J., Snoeys, J., and De Geest, B. (2009). Wild-type apo A-I and apo A-IMilano gene transfer reduce native and transplant arteriosclerosis to a similar extent. J. Mol. Med. 87, 287-297. doi: 10.1007/s00109-008-0427-y
10. Field, F. J., Watt, K., and Mathur, S. N. (2008). Origins of intestinal ABCA1-mediated HDL-cholesterol. J. Lipid Res. 49, 2605-2619. doi: 10.1194/jlr.M800302-JLR200
11. Guasch, A., Deen, W. M., and Myers, B. D. (1993). Charge selectivity of the glomerular filtration barrier in healthy and nephrotic humans. J. Clin. Invest. 92, 2274-2282. doi: 10.1172/JCI116831
12. Hirsh, B. J., Smilowitz, N. R., Rosenson, R. S., Fuster, V., and Sperling, L. S. (2015). Utilization of and adherence to guideline-recommended lipid-lowering therapy after acute coronary syndrome: opportunities for improvement. J. Am. Coll. Cardiol. 66, 184-192. doi: 10.1016/j.jacc.2015.05.030
13. Hovingh, G. K., Smits, L. P., Stefanutti, C., Soran, H., Kwok, S., de Graaf, J., et al. (2015). The effect of an apolipoprotein A-I-containing high-density lipoprotein-mimetic particle (CER-001) on carotid artery wall thickness in patients with homozygous familial hypercholesterolemia: the Modifying Orphan Disease Evaluation (MODE) study. Am. Heart J. 169, 736-742 e731. doi: 10.1016/j.ahj.2015.01.008
14. Khera, A. V., Cuchel, M., de la Llera-Moya, M., Rodrigues, A., Burke, M. F., Jafri, K., et al. (2011). Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N. Engl. J. Med. 364, 127-135. doi: 10.1056/NEJMoa1001689
15. Kootte, R. S., Smits, L. P., van der Valk, F. M., Dasseux, J. L., Keyserling, C. H., Barbaras, R., et al. (2015). Effect of open-label infusion of an apoA-I-containing particle (CER-001) on RCT and artery wall thickness in patients with FHA. J. Lipid Res. 56, 703-712. doi: 10.1194/jlr.M055665
16. Langmann, T., Klucken, J., Reil, M., Liebisch, G., Luciani, M. F., Chimini, G., et al. (1999). Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages. Biochem. Biophys. Res. Commun. 257, 29-33. doi: 10.1006/bbrc.1999.0406
17. Lewis, G. F., and Rader, D. J. (2005). New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ. Res. 96, 1221-1232. doi: 10.1161/01.RES.0000170946.56981.5c
18. Mattjus, P., and Slotte, J. P. (1996). Does cholesterol discriminate between sphingomyelin and phosphatidylcholine in mixed monolayers containing both phospholipids? Chem. Phys. Lipids 81, 69-80. doi: 10.1016/0009-3084(96)02535-2
19. Miyazaki, A., Sakuma, S., Morikawa, W., Takiue, T., Miake, F., Terano, T., et al. (1995). Intravenous injection of rabbit apolipoprotein A-I inhibits the progression of atherosclerosis in cholesterol-fed rabbits. Arterioscler. Thromb. Vasc. Biol. 15, 1882-1888. doi: 10.1161/01.ATV.15.11.1882
20. Nanjee, M. N., Doran, J. E., Lerch, P. G., and Miller, N. E. (1999). Acute effects of intravenous infusion of ApoA1/phosphatidylcholine discs on plasma lipoproteins in humans. Arterioscler. Thromb. Vasc. Biol. 19, 979-989. doi: 10.1161/01.ATV.19.4.979
21. Nieuwdorp, M., Vergeer, M., Bisoendial, R. J., op 't Roodt, J., Levels, H., Birjmohun, R. S., et al. (2008). Reconstituted HDL infusion restores endothelial function in patients with type 2 diabetes mellitus. Diabetologia 51, 1081-1084. doi: 10.1007/s00125-008-0975-2
22. Nissen, S. E., Tsunoda, T., Tuzcu, E. M., Schoenhagen, P., Cooper, C. J., Yasin, M., et al. (2003). Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA 290, 2292-2300. doi: 10.1001/jama.290.17.2292
23. Oram, J. F., Lawn, R. M., Garvin, M. R., and Wade, D. P. (2000). ABCA1 is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages. J. Biol. Chem. 275, 34508-34511. doi: 10.1074/jbc.M006738200
24. Piccolo, R., Giustino, G., Mehran, R., and Windecker, S. (2015). Stable coronary artery disease: revascularisation and invasive strategies. Lancet 386, 702-713. doi: 10.1016/S0140-6736(15)61220-X
25. Ramstedt, B., and Slotte, J. P. (1999). Interaction of cholesterol with sphingomyelins and acyl-chain-matched phosphatidylcholines: a comparative study of the effect of the chain length. Biophys. J. 76, 908-915. doi: 10.1016/S0006-3495(99)77254-1
26. Rigotti, A., Acton, S. L., and Krieger, M. (1995). The class B scavenger receptors SR-BI and CD36 are receptors for anionic phospholipids. J. Biol. Chem. 270, 16221-16224. doi: 10.1074/jbc.270.27.16221
27. Ross, R. (1999). Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 340, 115-126. doi: 10.1056/NEJM199901143400207
28. Shaw, J. A., Bobik, A., Murphy, A., Kanellakis, P., Blombery, P., Mukhamedova, N., et al. (2008). Infusion of reconstituted high-density lipoprotein leads to acute changes in human atherosclerotic plaque. Circ. Res. 103, 1084-1091. doi: 10.1161/CIRCRESAHA.108.182063
29. Suc, I., Brunet, S., Mitchell, G., Rivard, G. E., and Levy, E. (2003). Oxidative tyrosylation of high density lipoproteins impairs cholesterol efflux from mouse J774 macrophages: role of scavenger receptors, classes A and B. J. Cell Sci. 116, 89-99. doi: 10.1242/jcs.00126
30. Tardif, J. C., Ballantyne, C. M., Barter, P., Dasseux, J. L., Fayad, Z. A., Guertin, M. C., et al. (2014). Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial. Eur. Heart J. 35, 3277-3288. doi: 10.1093/eurheartj/ehu171
31. Tardif, J.-C., Grégoire, J., L'Allier, P. L., Ibrahim, R., Lespérance, J., Heinonen, T. M., et al. (2007). Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial. JAMA 297, 1675-1682. doi: 10.1001/jama.297.15.jpc70004
32. Tardy, C., Goffinet, M., Boubekeur, N., Ackermann, R., Sy, G., Bluteau, A., et al. (2014). CER-001, a HDL-mimetic, stimulates the reverse lipid transport and atherosclerosis regression in high cholesterol diet-fed LDL-receptor deficient mice. Atherosclerosis 232, 110-118. doi: 10.1016/j.atherosclerosis.2013.10.018
33. Tardy, C., Goffinet, M., Boubekeur, N., Cholez, G., Ackermann, R., Sy, G., et al. (2015). HDL and CER-001 Inverse-dose dependent inhibition of atherosclerotic plaque formation in apoE-/-mice: evidence of ABCA1 down-regulation. PLOS ONE 10:e0137584. doi: 10.1371/journal.pone.0137584
34. Tarling, E. J. (2013). Expanding roles of ABCG1 and sterol transport. Curr. Opin. Lipidol. 24, 138-146. doi: 10.1097/MOL.0b013e32835da122
35. van Leuven, S. I., Birjmohun, R. S., Franssen, R., Bisoendial, R. J., de Kort, H., Levels, J. H., et al. (2009). ApoAI-phosphatidylcholine infusion neutralizes the atherothrombotic effects of C-reactive protein in humans. J. Thromb. Haemost. 7, 347-354. doi: 10.1111/j.1538-7836.2008.03175.x